Guillaume Baxter

VC Investor - Partner @Sofinnova Partners

📍 Paris, Ile-de-France, France🔄 Updated September 2026💼 8 investments📅 11 years investing🗓 Last invested Oct 2023
VC🌍 France
8
Total investments
3
Early stage
0
Mid stage
1
Late stage
11y
Years active

Portfolio

6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Oct 2023
We are a French biotechnology company developing cutting-edge precision fermentation techniques, dedicated to take part in the environmental transition within the dairy production sector. Our innovative technology enables the production of dairy proteins without the need for animals, significantly reducing the ecological footprint. By providing our clients with cutting-edge, sustainable ingredients, we empower them to create a diverse range of dairy products identical to those you already love, both environmentally conscious and nutritionally rich. Join us on our journey to shaping a future where ethical dairy alternatives are complementary to conventional farming and contribute to a healthier planet.
Board Member
Jan 2023
Leather is loved. Leather is luxury. Leather is everywhere. Unfortunately, making leather is also polluting, challenging and controversial. Qorium creates beautiful, premium, and authentic leather without compromise. Cutting-edge science empowers us to dramatically reduce the vast impacts of today’s leather industry without quality reductions. By removing the cow from leather production, Qorium’s material has minimal climate impacts, low water and chemical usage, no land use, and no animal impacts. Simply put, Qorium reinvents leather. Better product. Better planet.
early stageBiotechnology
Board Observer
Apr 2020
By 2050, the world's population will surpass 10 billion people. To feed the current population and future generations we need to address global food challenges, today. How can we solve this problem without overwhelming the planet? And how can we deliver higher quality, more nutritious food for everyone? With Protera’s Natural Intelligence™ technology, we believe the future is already here. Protera’s technology uses predictive algorithms that calculate millions of amino acid combinations and simulate protein patterns in a matter of seconds. Our technology is based in Deep Learning and allows us to shine a light on a previously untapped universe of proteins. We craft protein-based ingredients faster and more affordably than ever before, unlocking a revolution in human health, reducing damage to the environment, and preventing food waste. Our first products already exceed the performance, scalability, and functionality of existing alternative ingredients. Please visit proterabio.com, contact us at (415)-256-7667, or email us at info@proterabio.com
Board Observer
2018
Micropep is an innovative plant biotechnology company developing the next generation of biological crop protection solutions based on the incredible potential of micropeptides; short natural peptide molecules that target and regulate plant genes and proteins.
Board Observer
2015
CelluComp is a new and dynamic material science company based in Scotland that is at the forefront of developing high-tech products from sustainable sources. At CelluComp we believe there are better and more sustainable options to materials compared to some of the chemically-based or petroleum-based materials that are used today, which is why our vision is to promote Material Change for Good. Our principle activity is to develop and commercialize Curran®, our material developed from the extraction of nano cellulose fibers of root vegetables, such as carrots and sugar beets. Curran® offers exceptional mechanical properties (stiffness, strength and light weight) compared to other fiber reinforcements at an affordable price. With our production partner and our customers, we are developing products for both the composite and paints and coatings industries. Curran® has the capability to enhance products in sporting goods, construction, paints & coatings, cosmetics, automobile, marine and many other potential applications.
late stageResearch
Board Observer
2015
DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAX™️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine.
Experience · 10 entries
All (10)
Investments (8)
Board (8)
2023
Board Observer
Oct 2023
We are a French biotechnology company developing cutting-edge precision fermentation techniques, dedicated to take part in the environmental transition within the dairy production sector. Our innovative technology enables the production of dairy proteins without the need for animals, significantly reducing the ecological footprint. By providing our clients with cutting-edge, sustainable ingredients, we empower them to create a diverse range of dairy products identical to those you already love, both environmentally conscious and nutritionally rich. Join us on our journey to shaping a future where ethical dairy alternatives are complementary to conventional farming and contribute to a healthier planet.
Board Member
Jan 2023
Leather is loved. Leather is luxury. Leather is everywhere. Unfortunately, making leather is also polluting, challenging and controversial. Qorium creates beautiful, premium, and authentic leather without compromise. Cutting-edge science empowers us to dramatically reduce the vast impacts of today’s leather industry without quality reductions. By removing the cow from leather production, Qorium’s material has minimal climate impacts, low water and chemical usage, no land use, and no animal impacts. Simply put, Qorium reinvents leather. Better product. Better planet.
early stageBiotechnology
2022
Board Member
Mar 2022
We make everyday products safe and sustainable. We aim to end chemical pollution in consumer products by replacing harmful petro-based ingredients.
2021
Board Observer
Jun 2021
Meiogenix advances crop improvement through proprietary breeding technologies based on precise, targeted recombination. By unlocking the natural diversity of crops, we enable breeders to deliver elite varieties that help farmers meet the challenges of productivity, sustainability and disease resilience.
Principal
Feb 2021
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact our collective future. Founded in 1972, Sofinnova Partners is a deeply-established venture capital firm in Europe, with 50 years of experience backing over 500 companies and creating market leaders around the globe. Today, Sofinnova Partners has over €4 billion under management. For more information, please visit: www.sofinnovapartners.com
Show all 10 entries ↓
Investment activity
2015–2023 · 8 investments
201522018120201202112022120232
Recent (last 2 years)Earlier